CRB2 and neoplasm: Notably for FAT4, BFAR, CRB2, and PEX14, we did not identify somatic mutations in the wild-type allele of these genes in the cases carrying germline mutations, suggesting that if they are contributing to tumor formation, they most likely do not function as classical tumor suppressors.